Atria Investments Inc Has $589,000 Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Atria Investments Inc lifted its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 16.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,663 shares of the real estate investment trust’s stock after buying an additional 4,474 shares during the period. Atria Investments Inc’s holdings in Sabra Health Care REIT were worth $589,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of SBRA. Sei Investments Co. raised its holdings in shares of Sabra Health Care REIT by 1.4% in the 1st quarter. Sei Investments Co. now owns 109,558 shares of the real estate investment trust’s stock worth $1,618,000 after buying an additional 1,469 shares in the last quarter. US Bancorp DE grew its position in Sabra Health Care REIT by 8.3% during the 1st quarter. US Bancorp DE now owns 22,412 shares of the real estate investment trust’s stock worth $331,000 after acquiring an additional 1,713 shares during the last quarter. Orion Portfolio Solutions LLC grew its position in Sabra Health Care REIT by 2.4% during the 1st quarter. Orion Portfolio Solutions LLC now owns 82,364 shares of the real estate investment trust’s stock worth $1,217,000 after acquiring an additional 1,962 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp grew its position in Sabra Health Care REIT by 31.9% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 55,909 shares of the real estate investment trust’s stock worth $822,000 after acquiring an additional 13,527 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Sabra Health Care REIT by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock worth $516,545,000 after acquiring an additional 838,654 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Stock Performance

SBRA stock opened at $18.57 on Wednesday. The business’s fifty day moving average is $18.63 and its 200-day moving average is $16.63. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The company has a market cap of $4.39 billion, a P/E ratio of 45.29, a price-to-earnings-growth ratio of 2.28 and a beta of 1.25. Sabra Health Care REIT, Inc. has a twelve month low of $12.83 and a twelve month high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The company had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same period last year, the company earned $0.34 EPS. Equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.46%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 292.69%.

Analyst Upgrades and Downgrades

SBRA has been the topic of a number of research analyst reports. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and increased their price target for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Scotiabank increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Truist Financial increased their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus target price of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.